CervoMed (CRVO) Income towards Parent Company (2010 - 2026)

CervoMed has reported Income towards Parent Company for 17 years, with the latest figure at -$8.1 million in Q1 2026.

• Quarterly Income towards Parent Company fell 52.04% year-over-year to -$8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.6 million (down 49.61% YoY) and the FY2025 annual result came in at -$27.0 million, down 48.34% from the prior year.
• Income towards Parent Company steadied at -$8.1 million in Q1 2026 per CRVO's latest filing, from -$8.1 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at -$1.2 million in Q2 2023 and troughed at -$8.1 million in Q1 2026.
• A 5-year average of -$4.6 million and a median of -$4.4 million in 2022 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2022 and 2024: Income towards Parent Company soared 77.06% in 2022, then sank 179.1% in 2024.
• Over 5 years, Income towards Parent Company stood at -$4.1 million in 2022, then jumped by 35.74% to -$2.6 million in 2023, then tumbled by 179.1% to -$7.3 million in 2024, then retreated by 10.67% to -$8.1 million in 2025, then fell by 0.33% to -$8.1 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$8.1 million, -$8.1 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.